We are live on
!
Find out more
Mackenzie Financial Portfolio holdings
AUM
$83.3B
1-Year Est. Return
31.19%
This Fund
S&P 500
This Quarter
Est. Return
+7.5%
1 Year Est. Return
+31.19%
3 Year Est. Return
+75.49%
5 Year Est. Return
+99.03%
10 Year Est. Return
+295.58%
AUM
$69.4B
AUM Growth
+$3.09B
(+4.7%)
Cap. Flow
-$1.1B
Cap. Flow
% of AUM
-1.58%
Top 10 Holdings %
Top 10 Hldgs %
21.76%
Holding
1,637
New
142
Increased
674
Reduced
560
Closed
116
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cadence Design Systems
CDNS
|
+$313M |
| 2 |
Visa
V
|
+$211M |
| 3 |
Brookfield Asset Management
BAM
|
+$201M |
| 4 |
Roper Technologies
ROP
|
+$103M |
| 5 |
Gartner
IT
|
+$82.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Synopsys
SNPS
|
+$417M |
| 2 |
ON Semiconductor
ON
|
+$286M |
| 3 |
AYX
Alteryx Inc
AYX
|
+$140M |
| 4 |
Bank of Montreal
BMO
|
+$128M |
| 5 |
Toronto Dominion Bank
TD
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.36% |
| 2 | Technology | 19.76% |
| 3 | Industrials | 13.24% |
| 4 | Healthcare | 9.04% |
| 5 | Energy | 8.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Boston Scientific
BSX
$69.5B
| $47.2M | 0.07% |
689,402
-19,431
| -3% | -$1.25M |
|
227
Automatic Data Processing
ADP
$106B
| $47M | 0.07% |
188,108
-1,333
| -0.7% | -$326K |
|
228
Micron Technology
MU
$930B
| $45.3M | 0.07% |
384,177
+51,345
| +15% | +$4.65M |
|
229
Alamos Gold
AGI
$11.6B
| $45.2M | 0.07% |
3,064,168
+52,294
| +2% | +$661K |
|
230
Medtronic
MDT
$109B
| $44.1M | 0.06% |
506,253
+28,741
| +6% | +$2.45M |
|
231
Workday
WDAY
$39.6B
| $43.9M | 0.06% |
161,008
-6,129
| -4% | -$1.74M |
|
232
Kroger
KR
$35.4B
| $43.9M | 0.06% |
768,476
+3,031
| +0.4% | +$149K |
|
233
United Rentals
URI
$67.2B
| $43.8M | 0.06% |
60,760
-27,499
| -31% | -$17.6M |
|
234
Generac Holdings
GNRC
$11.6B
| $43.6M | 0.06% |
346,006
+48,889
| +16% | +$5.73M |
|
235
Maravai LifeSciences
MRVI
$969M
| $43.5M | 0.06% |
5,016,316
-152,860
| -3% | -$1.03M |
|
236
Dominion Energy
D
$60.8B
| $41.6M | 0.06% |
846,611
+142,533
| +20% | +$6.66M |
|
237
AT&T
T
$159B
| $41.4M | 0.06% |
2,353,763
+95,658
| +4% | +$1.63M |
|
238
Allstate
ALL
$68B
| $41.2M | 0.06% |
238,110
+10,710
| +5% | +$1.69M |
|
239
TransAlta
TAC
$3.95B
| $40.4M | 0.06% |
6,294,773
-75,643
| -1% | -$537K |
|
240
Gilead Sciences
GILD
$162B
| $39.7M | 0.06% |
541,665
+6,108
| +1% | +$470K |
|
|
KW
241
DELISTED
Kennedy-Wilson Holdings
KW
| $39.6M | 0.06% |
4,617,255
+77,646
| +2% | +$764K |
|
242
ATS Corp
ATS
$2.64B
| $39.6M | 0.06% |
1,176,012
-26,042
| -2% | -$1.03M |
|
243
Verizon
VZ
$195B
| $39.4M | 0.06% |
939,679
-326,284
| -26% | -$13.2M |
|
244
Carrier Global
CARR
$51B
| $39.3M | 0.06% |
675,750
+112,402
| +20% | +$6.32M |
|
245
ICICI Bank
IBN
$108B
| $39.2M | 0.06% |
1,485,169
+72,461
| +5% | +$1.81M |
|
246
Vertex Pharmaceuticals
VRTX
$121B
| $38.6M | 0.06% |
92,452
+5,625
| +6% | +$2.38M |
|
247
Kraft Heinz
KHC
$30.7B
| $38.5M | 0.06% |
1,043,764
+246,744
| +31% | +$8.96M |
|
248
Humana
HUM
$43.7B
| $38.4M | 0.06% |
110,811
-10,935
| -9% | -$4.14M |
|
249
Elevance Health
ELV
$81.5B
| $38M | 0.05% |
73,191
-16,234
| -18% | -$8.07M |
|
250
Frontdoor
FTDR
$5.1B
| $37.6M | 0.05% |
1,154,794
-2,256,629
| -66% | -$73.1M |
|
Similar funds
Mackenzie Financial's Q1 2024 Portfolio in Review
As of Q1 2024, Mackenzie Financial held 1,637 positions worth $69.4B, up 4.7% from $66.3B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Mackenzie Financial's Q1 2024 filing shows 142 new, 674 increased, 560 reduced and 116 closed positions. Its largest new stake was Cognex: 1,284,682 shares worth $54.5M. The largest sale was Synopsys, an estimated $417M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 21% a quarter earlier, followed by Technology and Industrials.
- Mackenzie Financial's largest Q1 2024 buy was Cognex: 1,284,682 shares worth $54.5M.
- Mackenzie Financial added most to Cadence Design Systems in Q1 2024, an estimated $313M increase.
- Mackenzie Financial's biggest Q1 2024 reduction was Synopsys, cutting an estimated $417M.
- Mackenzie Financial fully exited Alteryx Inc in Q1 2024, selling an estimated $140M.
- Mackenzie Financial's ten largest holdings make up 22% of its $69.4B portfolio in Q1 2024.
- Mackenzie Financial opened 142 new positions and closed 116 in Q1 2024.
- Mackenzie Financial's portfolio value rose 4.7% quarter-over-quarter to $69.4B.
Based on Mackenzie Financial's 13F filing for Q1 2024, filed 10 May 2024.